1492 Capital Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

1492 Capital Management’s Portfolio PRTK Stock Details PRTK Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$1.29M	Buy
2022 Q2	$944K	Sell
2022 Q1	$1.51M	Buy
2021 Q4	$2.21M	Buy
2021 Q3	$2.37M	Buy
2021 Q2	$866K	Buy